Genenta Science SpA is a biotechnology business based in the US. Genenta Science SpA shares (GNTA) are listed on the NASDAQ and all prices are listed in US Dollars.
Its last market close was $3.83 – an increase of 8.81% over the previous week. Genenta Science SpA employs 14 staff and has a market cap (total outstanding shares value) of 0.00.Our top picks for where to buy Genenta Science SpA ADR stock
How to buy Genenta Science SpA stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GNTA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Genenta Science SpA stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Genenta Science SpA stock price (NASDAQ: GNTA)
Use our graph to track the performance of GNTA stocks over time.Genenta Science SpA stocks at a glance
Latest market close | $3.83 |
---|---|
52-week range | $2.20 - $7.28 |
50-day moving average | $4.65 |
200-day moving average | $4.19 |
Wall St. target price | $21.60 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.51 |
Is it a good time to buy Genenta Science SpA stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genenta Science SpA price performance over time
Historical closes compared with the close of $3.94 from 2025-02-06
1 week (2025-01-31) | 11.93% |
---|---|
1 month (2025-01-08) | -22.59% |
3 months (2024-11-08) | -19.59% |
6 months (2024-08-08) | -14.35% |
1 year (2024-02-08) | 21.23% |
---|---|
2 years (2023-02-07) | -37.26% |
3 years (2022-02-07) | 8.8661 |
5 years (2020-02-04) | N/A |
Genenta Science SpA financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -25.83% |
Return on equity TTM | -42.89% |
Profit margin | 0% |
Book value | $0.92 |
Market Capitalization | $72.1 million |
TTM: trailing 12 months
Genenta Science SpA stock dividends
We're not expecting Genenta Science SpA to pay a dividend over the next 12 months.
Genenta Science SpA stock price volatility
Over the last 12 months, Genenta Science SpA's stocks have ranged in value from as little as $2.2 up to $7.28. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genenta Science SpA's is 0.741. This would suggest that Genenta Science SpA's stocks are less volatile than average (for this exchange).
Genenta Science SpA overview
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages.
Frequently asked questions
What percentage of Genenta Science SpA is owned by insiders or institutions?Currently 38.683% of Genenta Science SpA stocks are held by insiders and 8.339% by institutions. How many people work for Genenta Science SpA?
Latest data suggests 14 work at Genenta Science SpA. When does the fiscal year end for Genenta Science SpA?
Genenta Science SpA's fiscal year ends in December. Where is Genenta Science SpA based?
Genenta Science SpA's address is: Via Olgettina No. 58, Milan, MI, Italy, 20132 What is Genenta Science SpA's ISIN number?
Genenta Science SpA's international securities identification number is: US36870W1009 What is Genenta Science SpA's CUSIP number?
Genenta Science SpA's Committee on Uniform Securities Identification Procedures number is: 36870W100
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
5 Best ETFs in Canada for 2025
Looing for the best performing ETF in Canada? Explore the best Canadian ETFs on the TSX for dividend, REIT, bond investing and more.
-
4 Best US ETFs for 2025
Looing for the best US ETF? Explore the best US ETFs, including top US dividend and Nasdaq funds.
-
10 best stock trading platforms and apps in Canada for 2025
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to buy US stocks in Canada
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
BMO InvestorLine review
Check out the pros and cons of BMO’s self-directed trading platform in our InvestorLine review.
-
How to trade options in Canada
What is options trading and are options better than stocks? Learn how options trading in Canada works.
-
How to buy stocks in Canada
Want to know how to buy and sell stocks in Canada? Find out what you need to know in this simple, step-by-step guide.